Hipometilirajući agens (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hipometilirajući agens" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

2^nd place

4^th place

3^rd place

low place

2,251^st place

low place

bloodjournal.org

Garcia-Manero G (November 2008). „Demethylating agents in myeloid malignancies”. Curr Opin Oncol 20 (6): 705–10. DOI:10.1097/CCO.0b013e328313699c. PMID 18841054.
Hambach L, Ling KW, Pool J, et al. (December 2008). „Hypomethylating drugs convert HA-1 negative solid tumors into targets for stem cell based immunotherapy”. Blood 113 (12): 2715–22. DOI:10.1182/blood-2008-05-158956. PMID 19096014.
Aribi A, Borthakur G, Ravandi F, et al. (February 2007). „Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia”. Cancer 109 (4): 713–7. DOI:10.1002/cncr.22457. PMID 17219444.
De Padua Silva L, de Lima M, Kantarjian H, et al. (January 2009). „Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome”. Bone Marrow Transplant. 43 (11): 839–43. DOI:10.1038/bmt.2008.400. PMID 19151791.
Garcia-Manero G, Stoltz ML, Ward MR, Kantarjian H, Sharma S (September 2008). „A pilot pharmacokinetic study of oral azacitidine”. Leukemia 22 (9): 1680–4. DOI:10.1038/leu.2008.145. PMID 18548103.

Garcia-Manero G (November 2008). „Demethylating agents in myeloid malignancies”. Curr Opin Oncol 20 (6): 705–10. DOI:10.1097/CCO.0b013e328313699c. PMID 18841054.
Hambach L, Ling KW, Pool J, et al. (December 2008). „Hypomethylating drugs convert HA-1 negative solid tumors into targets for stem cell based immunotherapy”. Blood 113 (12): 2715–22. DOI:10.1182/blood-2008-05-158956. PMID 19096014.
Aribi A, Borthakur G, Ravandi F, et al. (February 2007). „Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia”. Cancer 109 (4): 713–7. DOI:10.1002/cncr.22457. PMID 17219444.
De Padua Silva L, de Lima M, Kantarjian H, et al. (January 2009). „Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome”. Bone Marrow Transplant. 43 (11): 839–43. DOI:10.1038/bmt.2008.400. PMID 19151791.
Garcia-Manero G, Stoltz ML, Ward MR, Kantarjian H, Sharma S (September 2008). „A pilot pharmacokinetic study of oral azacitidine”. Leukemia 22 (9): 1680–4. DOI:10.1038/leu.2008.145. PMID 18548103.